Table 3.
Differentially expressed (> 2-folds) soluble factors in rDFSC-CM compared with serum-free control medium identified by a protein array
| Ratio | References | |
|---|---|---|
| Anti-inflammation | ||
| TSP-1 | 105.9 | [35] |
| ACTH | 96.5 | [36] |
| TRAIL | 23.0 | [37] |
| AMPK-α1 | 10.4 | [38] |
| FGF-2 | 3.1 | [39] |
| Odonto/osteogenesis | ||
| OPN | 69.5 | [40] |
| Leptin | 68.1 | [41] |
| TGF-β3 | 18.6 | [42] |
| EGFR | 8.6 | [43] |
| MMP-2 | 4.2 | [44] |
| β-Catenin | 3.3 | [45] |
| Angiogenesis | ||
| VEGF | 38.4 | [46] |
| VEGF-C | 24.4 | [47] |
| FGF-BP | 15.5 | [48] |
| FSL-1 | 11.9 | [49] |
| TIE-2 | 8.2 | [50] |
| Neuroprotection | ||
| NGFR | 640.5 | [51] |
| NRP-2 | 74.5 | [52] |
| Orexin A | 42.7 | [53] |
| MUSK | 24.4 | [54] |
| GFR-α2 | 6.9 | [55] |
| BDNF | 4.6 | [56] |
| Pro-proliferation/anti-apoptosis | ||
| TIMP-1 | 87.5 | [57] |
| TIMP-2 | 3.1 | [58] |
| Ubiquitin | 17.9 | [59] |
| CXCR-4 | 5.4 | [60] |